Skip to main content
. 2026 Sep 15;17:1902465. doi: 10.3389/fphys.2026.1902465

Table 1.

Comparison of baseline demographic and clinical characteristics from different hospitals in one-year follow-up.

Variable Total Zhong Shan Hospital of Xiamen Ji Nan University χ2 /Z P
(N =370) (N = 320) (N = 50)
Sex, n (%)
Male 268 (72.4) 228 (71.3) 40 (80.0) 1.658a 0.198
Female 102 (27.6) 92 (28.7) 10 (20.0)
Age, (Years) 28.0 (22.0, 35.2) 28.0 (22.0, 35.0) 29.5 (20.0, 36.5) -0.060b 0.952
Course of diagnosis, (Months) 0.0 (0.0, 9.0) 0.0 (0.0, 12.0) 0.0 (0.0, 1.0) -3.211b 0.001*
Symptoms to diagnosis, (Months) 6.0 (0.5, 24.0) 6.0 (0.0, 24.0) 6.0 (2.8, 17.0) -1.262b 0.207
Duration, (Years) 12.0 (4.0, 45.0) 13.0 (5.0, 48.0) 8.5 (3.0, 17.0) -2.913b 0.004*
Age of onset, (Years) 26.0 (20.0, 33.0) 26.0 (20.0, 33.0) 28.5 (18.0, 35.2) -0.409b 0.683
BMI, (kg/m2) 19.0 (17.3, 21.5) 19.0 (17.3, 21.5) 18.6 (17.2, 21.6) -0.252b 0.801
Smoking history, n (%)
No 323 (87.3) 279 (87.2) 44 (88.0) 0.026a 0.873
Yes 47 (12.7) 41 (12.8) 6 (12.0)
Alcohol consumption history, n (%)
No 340 (91.9) 293 (91.6) 47 (94.0) 0.095a 0.758
Yes 30 (8.1) 27 (8.4) 3 (6.0)
Hepatitis B, n (%)
No 333 (90.0) 286 (89.4) 47 (94.0) 1.028a 0.311
Yes 37 (10.0) 34 (10.6) 3 (6.0)
Abdominal_history, n (%)
No 192 (51.9) 157 (49.1) 35 (70.0) 7.594a 0.006*
Yes 178 (48.1) 163 (50.9) 15 (30.0)
Disease behavior, n (%)
No-stricturing & No-penetrating 113 (30.5) 90 (28.1) 23 (46.0) 9.151a 0.010*
Stricturing 173 (46.8) 159 (49.7) 14 (28.0)
penetrating 84 (22.7) 71 (22.2) 13 (26.0)
Lesion location, n (%)
L1 55 (14.9) 45 (14.1) 10 (20) 21.539a <0.001*
L2 47 (12.7) 44 (13.8) 3 (6)
L3 137 (37) 106 (33.1) 31 (62)
L4 7 (1.9) 7 (2.2) 0 (0)
Merge 124 (33.5) 118 (36.9) 6 (12)
Diarrhea, n (%)
No 103 (27.8) 91 (28.4) 12 (24.0) 0.424a 0.515
Yes 267 (72.2) 229 (71.6) 38 (76.0)
Abdominal pain, n (%)
No 57 (15.4) 53 (16.6) 4 (8.0) 2.433a 0.119
Yes 313 (84.6) 267 (83.4) 46 (92.0)
Abdominal bloating, n (%)
No 282 (76.2) 252 (78.8) 30 (60.0) 8.387a 0.004*
Yes 88 (23.8) 68 (21.3) 20 (40.0)
Gastrointestinal bleeding, n (%)
No 255 (68.9) 233 (72.8) 22 (44.0) 16.759a <0.001*
Yes 115 (31.1) 87 (27.2) 28 (56.0)
Weight loss, n (%)
No 218 (58.9) 184 (57.5) 34 (68.0) 1.970a 0.160
Yes 152 (41.1) 136 (42.5) 16 (32.0)
Vomiting, n (%)
No 321 (86.8) 277 (86.6) 44 (88.0) 0.078a 0.780
Yes 49 (13.2) 43 (13.4) 6 (12.0)
Nausea, n (%)
No 312 (84.3) 270 (84.4) 42 (84.0) 0.005a 0.946
Yes 58 (15.7) 50 (15.6) 8 (16.0)
Fever, n (%)
No 302 (81.6) 261 (81.6) 41 (82.0) 0.006a 0.941
Yes 68 (18.4) 59 (18.4) 9 (18.0)
Anemia, n (%)
None 160 (43.2) 137 (42.8) 23 (46.0) -0.244b 0.807
Mild 155 (41.9) 139 (43.4) 16 (32.0)
Moderate 50 (13.5) 40 (12.5) 10 (20.0)
Severe 5 (1.4) 4 (1.3) 1 (2.0)
Poor appetite, n (%)
No 273 (73.8) 237 (74.1) 36 (72.0) 0.095a 0.758
Yes 97 (26.2) 83 (25.9) 14 (28.0)
Fatigue, n (%)
No 303 (81.9) 259 (80.9) 44 (88.0) 1.455a 0.228
Yes 67 (18.1) 61 (19.1) 6 (12.0)
Another organ complication history, n (%)
No 327 (88.4) 281 (87.8) 46 (92.0) 0.738a 0.390
Yes 43 (11.6) 39 (12.2) 4 (8.0)
Abdominal complication history, n (%)
No 308 (83.2) 268 (83.8) 40 (80.0) 0.436a 0.509
Yes 62 (16.8) 52 (16.3) 10 (20.0)
Anal complication history, n (%)
No 162 (43.8) 123 (38.4) 39 (78.0) 27.499a <0.001*
Yes 208 (43.8) 197 (61.6) 11 (22.0)
Frequency of Loose Stools 10.0 (0.0, 21.0) 10.0 (0.0, 20.0) 14.0 (7.0, 21.0) -2.727b 0.006*
Abdominal Pain Severity (0-3) 7.0 (2.0, 14.0) 10.0 (7.0, 14.0) 1.0 (1.0, 2.0) -7.388b <0.001*
General Condition (0-4) 14.0 (7.0, 17.0) 14.0 (11.0, 18.0) 2.0 (1.0, 2.0) -11.415b <0.001*
Extramural complications, n (%)
0 155 (41.9) 111 (34.7) 44 (88.0) -6.714a <0.001*
1 130 (35.1) 125 (39.1) 5 (10.0)
2 72 (19.5) 71 (22.2) 1 (2.0)
3 11 (3.0) 11 (3.4) 0 (0.0)
4 2 (0.5) 2 (0.6) 0 (0.0)
Opioid antidiarrheal medications, n (%)
No 369 (99.7) 320 (100.0) 49 (98.0) 1.142a 0.135
Yes 1 (0.3) 0 (0.0) 1 (2.0)
Reduced Hematocrit 2.0 (0.0, 5.9) 2.1 (0.0, 5.7) 1.9 (-2.6, 7.5) -0.605b 0.546
(Standard - Actual) / Standard Weight 13.0 (2.9, 22.2) 12.7 (3.1, 22.3) 14.1 (1.6, 22.0) -0.131b 0.896
CDAI Score 222.8 (153.3, 260.2) 229.8 (179.3, 267.2) 79.0 (51.0, 110.5) -9.602b <0.001*
Activity, n (%)
Remission 87 (23.5) 43 (13.4) 44 (88.0) 133.677a <0.001*
Active 283 (76.5) 277 (86.6) 6 (12.0)
WBC (×10^9) 6.6 (5.2, 8.7) 6.5 (5.1, 8.5) 8.1 (5.7, 10.4) -2.650b 0.008*
RBC (×10^12) 4.5 (4.0, 5.0) 4.5 (4.0, 5.0) 4.7 (4.2, 5.0) -1.733b 0.083
HB (g/L) 117.5 (102.0, 133) 117.5 (102.0, 132.0) 118.5 (98.5, 135.0) -0.065b 0.948
MCV (fL) 83.9 (78.0, 88.0) 84.2 (78.9, 88.0) 81.7 (72.9, 88.1) -1.801b 0.072
MCH (Pg) 26.9 (24.2, 28.5) 27.0 (24.3, 28.6) 25.9 (22.6, 28.4) -1.957b 0.050*
MCHC (g/L) 318.4 (307.0, 329.0) 319.0 (307.0, 329.0) 315.3 (308.5, 324.8) -0.725b 0.469
HCT (%) 36.9 (32.8, 40.9) 36.9 (33.2, 40.7) 37.5 (31.7, 42.6) -0.218b 0.827
PLT (×10^9) 325.5 (256.8, 404.0) 325.5 (258.0, 403.8) 328.9 (250.3, 409.9) -0.143b 0.886
ESR (mm/h) 26.6 (15.8, 47.7) 26.3 (15.0, 46.5) 40.0 (21.8, 56.2) -2.181b 0.029*
CRP (mg/L) 17.1 (5.0, 51.1) 17.0 (5.0, 45.7) 26.2 (5.6, 65.2) -1.349b 0.177
TP (g/L) 69.7 (63.2, 75.1) 70.2 (63.9, 75.2) 68.2 (61.4, 72.6) -2.042b 0.041*
ALB (g/L) 37.0 (32.9, 40.6) 37.0 (32.9, 40.6) 37.0 (32.4, 40.7) -0.092b 0.926
Urea Nitrogen (mmol/L) 3.7 (3.0, 4.6) 3.7 (3.0, 4.6) 3.8 (3.0, 5.0) -0.863b 0.388
Serum Potassium (mmol/L) 3.9 (3.6, 4.2) 3.9 (3.6, 4.1) 4.1 (3.7, 4.3) -2.918b 0.004*
Uric Acid (μmol/L) 333.8 (266.5, 393.5) 330.1 (262.0, 390.0) 354.6 (307.5, 411.6) -1.879b 0.060
HDL (mmol/L) 1.0 (0.8, 1.1) 1.0 (0.8, 1.1) 1.0 (0.7, 1.3) -0.467b 0.640
Cholesterol (mmol/L) 3.5 (3.0, 4.1) 3.5 (3.0, 4.1) 3.9 (3.2, 4.5) -2.624b 0.009*
Triglycerides (mmol/L) 0.9 (0.7, 1.2) 0.9 (0.7, 1.2) 0.9 (0.8, 1.1) -0.702b 0.482
Folic Acid (nmol/L) 11.5 (7.6, 16.2) 12.1 (7.9, 16.7) 9.5 (7.3, 11.9) -2.879b 0.004*
VitB12 (pmmol/L) 310.7 (260.7, 384.8) 299.0 (251.2, 379.2) 375.3 (327.5, 412.3) -4.462b <0.001*
Fe (umol/L) 8.4 (5.2, 11.8) 8.8 (5.1, 11.8) 7.5 (5.4, 11.4) -0.400b 0.689
Total Iron-Binding Capacity (umol/L) 48.9 (42.0,54.4) 48.0 (41.2,54.1) 52.9 (47.2,57.2) -3.512b <0.001*
Serum Ferritin (ng/mL) 128.0 (66.5, 205.1) 122.4 (63.0, 202.8) 156.6 (119.5, 219.5) -2.446b 0.014*
Serum Transferrin (g/L) 2.0 (1.8, 2.2) 2.0 (1.8, 2.2) 2.0 (1.7, 2.1) -1.089b 0.276
Soluble Transferrin Receptor (mg/L) 1.3 (1.1, 1.6) 1.2 (1.1, 1.5) 31.7 (1.8, 31.8) -8.734b <0.001*
Fecal occult blood, n (%)
No 74 (20.0) 57 (17.8) 17 (34.0) 7.082a 0.008*
Yes 296 (80.0) 263 (82.2) 33 (66.0)
Calprotectin, n (%)
No 11 (3.0) 11 (3.4) 0 (0.0) 0.780a 0.377
Yes 359 (97.0) 309 (96.6) 50 (100.0)
Fibrinogen (mg/L) 4.0 (3.2, 4.7) 3.9 (3.2, 4.7) 4.3 (3.3, 5.3) -1.644b 0.100
D-Dimer(mg/L) 0.3 (0.2, 0.6) 0.3 (0.2, 0.6) 0.4 (0.2, 0.8) -2.486b 0.013*
Total enteral nutrition, n (%)
No 268 (72.4) 230 (71.9) 38 (76.0) 0.368a 0.544
Yes 102 (27.6) 90 (28.1) 12 (24.0)

Continuous data exhibiting a non-normal distribution are summarized as medians (IQR), while categorical variables are presented as frequencies and percentages.

*p < 0.05. a: Calculated via Chi-square test. b: Calculated via Mann-Whitney U test.